Costs and Expenses in USD of Orchard Therapeutics plc from 2016 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Orchard Therapeutics plc quarterly/annual Costs and Expenses history and growth rate from 2016 to Q3 2023.
  • Orchard Therapeutics plc Costs and Expenses for the quarter ending September 30, 2023 was $27.9M, a 10.7% decline year-over-year.
  • Orchard Therapeutics plc Costs and Expenses for the twelve months ending September 30, 2023 was $124M, a 16.3% decline year-over-year.
  • Orchard Therapeutics plc annual Costs and Expenses for 2022 was $150M, a 5.37% increase from 2021.
  • Orchard Therapeutics plc annual Costs and Expenses for 2021 was $142M, a 10.9% decline from 2020.
  • Orchard Therapeutics plc annual Costs and Expenses for 2020 was $160M, a 9.02% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)

Orchard Therapeutics plc Quarterly Costs and Expenses (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $124M $27.9M -$3.34M -10.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $127M $29.9M -$6.94M -18.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $134M $27.5M -$15.6M -36.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $150M $38.6M +$1.68M +4.55% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-14
Q3 2022 $148M $31.2M -$2.87M -8.41% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $151M $36.8M +$804K +2.23% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $150M $43.1M +$8.02M +22.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $142M $36.9M -$1.98M -5.08% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $144M $34.1M +$5.81M +20.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $138M $36M -$11.4M -24.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $150M $35.1M -$9.9M -22% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $160M $38.9M -$10.7M -21.7% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-02
Q3 2020 $170M $28.3M -$15M -34.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $185M $47.4M -$6.73M -12.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $192M $45M +$16.7M +59% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $175M $49.6M +$20.1M +68.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 $155M $43.3M +$7.85M +22.1% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-02
Q2 2019 $147M $54.2M -$104M -65.8% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-02
Q1 2019 $252M $28.3M +$14.6M +106% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-02
Q4 2018 $237M $29.5M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 $35.5M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 $158M Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 $13.7M Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27

Orchard Therapeutics plc Annual Costs and Expenses (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $150M +$7.64M +5.37% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 $142M -$17.5M -10.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $160M -$15.8M -9.02% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $175M -$61.7M -26% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 $237M +$199M +516% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 $38.5M +$19.3M +101% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $19.2M Jan 1, 2016 Dec 31, 2016 20-F 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.